A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
暂无分享,去创建一个
Mingli Xiang | Liang Ma | Li-juan Chen | Hao Zheng | Chong-yang Deng | Wei Jiang | Caifeng Xie | Zhi-zhi Chen | Ling Cheng | Shilin Li